IMV (TSE:IMV) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, November 8th. Analysts expect the company to announce earnings of C($0.12) per share for the quarter.
IMV (TSE:IMV) last announced its quarterly earnings results on Thursday, August 8th. The company reported C($0.10) EPS for the quarter, beating analysts’ consensus estimates of C($0.13) by C$0.03. The firm had revenue of C$0.19 million during the quarter, compared to analyst estimates of C$0.10 million.
Shares of IMV stock opened at C$3.95 on Thursday. The stock has a market cap of $166.51 million and a P/E ratio of -7.50. The company has a debt-to-equity ratio of 44.63, a current ratio of 5.74 and a quick ratio of 5.01. The company has a fifty day moving average price of C$3.65 and a two-hundred day moving average price of C$4.17. IMV has a one year low of C$3.01 and a one year high of C$8.49.
IMV Inc, a clinical-stage immuno-oncology company, together with its subsidiaries, develops products based on its platform and products with a primary focus on T cell activating therapies for cancer. The company's DPX drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system.
Receive News & Ratings for IMV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMV and related companies with MarketBeat.com's FREE daily email newsletter.